Healthcare ETFs are a popular way for retail investors to tap into a sector that historically offers resilience during market turbulence. With the crypto market hovering near flat levels (BTC down 0.017 % and ETH down 0.329 % in the last 24 h) and a fear‑greed reading of 23, many are turning to defensive plays. The choice between Fidelity’s FHLC and BlackRock’s BBH comes down to a few key distinctions.
FHLC is built around a U.S.‑centric index, giving investors exposure to the biggest domestic names in pharmaceuticals, medical devices, and biotech. Its lower expense ratio and concentrated holdings can translate into tighter tracking of the domestic healthcare landscape. BBH, on the other hand, pulls in a wider array of global stocks, which can broaden diversification but also introduce currency and geopolitical risk. The fee structure for BBH is typically higher, reflecting its broader index methodology.
When deciding which ETF to add to a portfolio, consider your risk tolerance and the level of diversification you want. If you prefer a more focused, lower‑cost approach that mirrors the U.S. market, FHLC may be the better buy. If you’re comfortable with a broader global exposure and are willing to pay a slightly higher fee for that breadth, BBH could be the right fit. As earnings season approaches and regulatory headlines—such as new tax rules for crypto—continue to watch how these factors influence the broader healthcare sector.